This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by identifying potential nutraceutical applications of bioactive compounds for prevention and treatment of Alzheimer's Disease.
This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by considering the neuroprotective properties of nutraceuticals such as soy, peanuts, and ginsenoside Rg1.
